É. Eschwège
Inserm · 433 works · 19,078 citations · h-index 63
Top works
- COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
- Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria
- Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
- "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
- High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
- High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men
- Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later.
- Use of HbA1c in Predicting Progression to Diabetes in French Men and Women
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
- Risk Factors for NIDDM in White Population: Paris Prospective Study
- Effect of Multiple Daily Insulin Injections on the Course of Diabetic Retinopathy
- Low Dosage and Long Treatment Duration of β-Lactam
- Is there a glycemic threshold for mortality risk?
- Diabetes Mellitus in Tunisia: Description in Urban and Rural Populations
- Insulin and Cardiovascular Disease: Paris Prospective Study
- Evaluation of risk factors for development of complications in Type II diabetes in Europe
- Delayed progression of diabetic retinopathy by divided insulin administration: A further follow-up
- Determinants and nature of dietary underreporting in a free-living population: the Fleurbaix Laventie Ville Santé (FLVS) study
- Revision of diagnostic criteria for diabetes
- Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status.